# A Prognostic Tool for Early Stage CLL

> **NCT03436524** · — · COMPLETED · sponsor: **Oncology Institute of Southern Switzerland** · enrollment: 4933 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03436524
- **Lead sponsor:** Oncology Institute of Southern Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 4933 (ACTUAL)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436524, "A Prognostic Tool for Early Stage CLL". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03436524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*